FGF7 and colitis: Several inflammatory disease models were used to investigate the impact of recombinant FGF7 on inflammation: in a model of colitis in rats and in mice, administration of recombinant FGF7 after colitis induction decreased the damage to the intestine mucosa and was associated with diminished cell death (Zeeh et al., 1996; Egger et al., 1999).